Global radiopharmaceutical company Cyclopharm (ASX:CYC) has entered into a standard commercial partnership with Yale following Technegas’ approval by the U.S. FDA | https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02766065-2A1501471
No gainer or loser data available.
